The FDA has called into question its health claim finding a link between consumption of soy protein and reduced risk of heart disease. Since 1999, the FDA has allowed manufacturers and advertisers to label soy products with an “authorized” claim of soy’s heart-health benefits.
However, proposed rulemaking may reduce it to a “qualified” claim of such benefits, which has a lower scientific standard, or rescind the claim altogether. The potential revocation follows numerous studies published since 1999 that present inconsistent findings on the relationship between soy protein and heart disease.
To read more, please visit adlawbyrequest.com.